![Amy VandenBerg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Amy VandenBerg worked as a Vice President of Regulatory and Clinical Affairs at Obalon Therapeutics, Inc. from 2014 to 2019.
Prior to that, she worked as a Director of Regulatory Affairs at DexCom, Inc. from 2006 to 2008 and as a Manager of Clinical Trials at Cygnus, Inc. Additionally, she earned an undergraduate degree from St. Mary's College of California in 1998.
Anciens postes connus de Amy VandenBerg
| Sociétés | Poste | Fin |
|---|---|---|
| DEXCOM, INC. | Conseiller Juridique Général | 01/12/2008 |
Cygnus, Inc.
 Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Corporate Officer/Principal | - |
| VYOME HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Amy VandenBerg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Health Technology |
Obalon Therapeutics, Inc.
 Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical balloon technology for weight loss therapy | Health Technology |
DexCom, Inc.
 DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
St. Mary's College of California
 St. Mary's College of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
